Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes
Clinical trial NCT05105919 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05105919
- Sponsor
- Montreal Heart Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-26
- Primary completion
- 2024-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.